Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial-Reference-Cited by-同舟云学术

Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial

Published:2011-12-15 Issue:6 Volume:27 Page:2255-2263
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Evans Marc,Bain Stephen C.,Hogan Simon,Bilous Rudy W.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/27/6/2255/17172340/gfr696.pdf

Reference38 articles.

1. Global estimates of the prevalence of diabetes for 2010 and 2030;Shaw;Diabetes Res Clin Pract,2010

2. The 2007 ERA-EDTA Registry Annual Report—a Precis;Stel;NDT Plus,2009

3. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006;Kramer;Nephrol Dial Transplant,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coste-efectividad del ciclosilicato de sodio y zirconio para el tratamiento de la hiperpotasemia en pacientes con enfermedad renal crónica o insuficiencia cardiaca en España;Nefrología;2024-09

2. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

3. Cost‐effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore;Nephrology;2024-03-05

4. Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait;Journal of Medical Economics;2024-02-14

5. Cost-effectiveness analysis of sodium zirconium cyclosilicate for treating hyperkalemia among Chinese patients;Frontiers in Public Health;2023-12-07